PROTEINURIA
Clinical trials for PROTEINURIA explained in plain language.
Never miss a new study
Get alerted when new PROTEINURIA trials appear
Sign up with your email to follow new studies for PROTEINURIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to protect transplanted kidneys from damage
Disease control Recruiting nowThis study is testing whether a medication called sparsentan can safely reduce protein in the urine of kidney transplant patients whose original kidney disease has returned. About 20 adult participants who received a transplant at least one year ago will take the daily tablet for…
Matched conditions: PROTEINURIA
Phase: PHASE4 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 20:11 UTC
-
New hope for kids with failing kidneys in major drug trial
Disease control Recruiting nowThis study is testing whether adding a new oral medicine called finerenone to standard kidney care helps children with chronic kidney disease. Researchers want to see if the combination reduces protein leaking into urine better than standard care alone. About 219 children, aged 6…
Matched conditions: PROTEINURIA
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope for young kidneys: extended safety trial for pediatric kidney disease treatment
Disease control Recruiting nowThis study aims to learn about the long-term safety of a medication called finerenone when given to children and young adults (ages 1-18) who have chronic kidney disease and proteinuria. Participants will take finerenone along with their standard kidney medication for up to 18 mo…
Matched conditions: PROTEINURIA
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug combo aims to protect kidneys from scarring
Disease control Recruiting nowThis study is testing whether combining two existing medicines—budesonide and ambrisentan—can help people with IgA nephropathy, a kidney disease. Researchers want to see if this combination reduces protein in urine and slows the decline of kidney function over 36 weeks. The study…
Matched conditions: PROTEINURIA
Phase: PHASE4 • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug duo aims to halt silent kidney damage
Disease control Recruiting nowThis study is testing whether combining two existing drugs, rituximab and cyclosporine, is safe and more effective for treating membranous nephropathy, an autoimmune disease that damages the kidneys' filters. The goal is to reduce harmful protein loss in urine and achieve lasting…
Matched conditions: PROTEINURIA
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Scientists probe why new kidneys leak protein
Knowledge-focused Recruiting nowThis study aims to understand why some patients develop protein in their urine immediately after receiving a kidney transplant, especially those with a specific kidney disease called FSGS. Researchers will review medical records and analyze blood and kidney tissue samples from up…
Matched conditions: PROTEINURIA
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Scientists search for hidden clues in Kids' high blood pressure
Knowledge-focused Recruiting nowThis study aims to understand the underlying causes of high blood pressure in children and how it damages the heart and kidneys. Researchers will follow 125 children and teens, some with newly diagnosed high blood pressure and some healthy, for two years. They will collect blood …
Matched conditions: PROTEINURIA
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Mar 13, 2026 15:05 UTC